Study of Safety and Efficacy of INC280 and Cetuximab, in Adult c-MET Positive mCRC and HNSCC Patients After Progression on Cetuximab or Panitumumab Therapy

Clinical trial NCT02205398 · TERMINATED

Trial details

NCT number

NCT02205398

Sponsor

Novartis Pharmaceuticals

Status

TERMINATED

Phase

Phase 1

Study type

INTERVENTIONAL

Start date

2014-07-28

Primary completion

2017-01-20

Enrollment

13

View on ClinicalTrials.gov